Nantahala Capital Management, LLC
Position in QNCX — Quince Therapeutics, Inc.
CIK 1472322
New Canaan, CT
Position in QNCX
as of Dec 31, 2025
· filed Feb 13, 2026
Position Value
$1,790,527,430
+$788,491,776 QoQ
Shares Held
2,672,429
-13.1% QoQ
Ownership
16.4%
of shares outstanding
% of Portfolio
52.29%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in QNCX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Nantahala Capital Management, LLC holds $599,967,806 across 52 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SLNO |
Soleno Therapeutics Inc
|
1,744,124 | $58,393,271 | |
| 2 | SVRA |
Savara Inc
|
7,344,783 | $40,102,515 | |
| 3 | IMUX |
Immunic, Inc.
|
2,506,491 | $27,822,050 | |
| 4 | TNGX |
Tango Therapeutics, Inc.
|
1,250,452 | $26,159,455 | |
| 5 | LBRX |
Lb Pharmaceuticals Inc
|
1,052,894 | $25,964,366 | |
| 6 | MLYS |
Mineralys Therapeutics, Inc.
|
895,481 | $24,258,580 | |
| 7 | ZVRA |
Zevra Therapeutics, Inc.
|
2,521,936 | $23,504,443 | |
| 8 | FULC |
Fulcrum Therapeutics, Inc.
|
3,050,040 | $23,393,806 |
All Filings in QNCX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $1,790,527,430 | 2,672,429 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,002,035,654 | 3,073,729 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $834,339,660 | 2,528,302 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||